Germany
Japan
United Kingdom
China
Antibodies
Download
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
USD 524.00
In Stock
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against PROX1 (Center)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PROX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 185-214 amino acids from the Central region of human PROX1. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against SOX2 - Embryonic Stem Cell Marker
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Sheep |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human SOX2 protein (within residues 1-100). [Swiss-Prot# P48431] |
USD 515.00
In Stock
Rabbit polyclonal RUNX1 Antibody (S276)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This RUNX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 227-255 amino acids from human RUNX1. |
Rabbit polyclonal KLF5 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-370 amino acids from the C-terminal region of human KLF5. |
TGF beta 1 (TGFB1) mouse monoclonal antibody, clone 8C4, Azide Free
| Applications | ELISA, FN, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
PIM1 Antibody (C-term ) Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PIM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 374-404 amino acids from the C-terminal region of human PIM1. |
Rabbit Polyclonal CCR5 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | CCR5 antibody was raised against a 15 amino acid peptide near the amino terminus of human CCR5. The immunogen is located within the first 50 amino acids of CCR5. |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
WISP2 Rabbit Polyclonal (aa102-117) Antibody
| Applications | IHC |
| Reactivities | Human |
| Immunogen | WISP2 antibody was raised against synthetic peptide from human WISP2. |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- IHC
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Target Symbol
- MKI67 (54)
- PECAM1 (43)
- ABCB1 (34)
- PTPRC (33)
- CD4 (32)
- EPCAM (30)
- JUN (29)
- CTNNB1 (28)
- NCAM1 (25)
- PIK3CG (23)
- PROCR (23)
- KIT (22)
- GLI1 (20)
- AKT1 (19)
- CD44 (18)
- CDH1 (18)
- BCL2 (17)
- KRT7 (17)
- TNFRSF8 (17)
- BSG (16)
- EGFR (15)
- FCGR2A (15)
- NKX2-1 (14)
- VIM (14)
- GFAP (13)
- L1CAM (13)
- MCAM (13)
- SERPINA1 (12)
- CD34 (11)
- ENPEP (11)
- GATA3 (11)
- MAPK9 (11)
- NEUROG1 (11)
- TNNI3 (11)
- CDX2 (10)
- FGF21 (10)
- HES1 (10)
- ID3 (10)
- SMAD1 (10)
- ANPEP (9)
- CD14 (9)
- CD8A (9)
- FN1 (9)
- HGF (9)
- NOTCH1 (9)
- STAT5A (9)
- CSF2 (8)
- ID2 (8)
- NES (8)
- SDC1 (8)
- CASP3 (7)
- CDH2 (7)
- DVL2 (7)
- LHX1 (7)
- PDX1 (7)
- VCAM1 (7)
- BCL2L1 (6)
- CDCP1 (6)
- CSF1 (6)
- CSF3 (6)
- GCG (6)
- IGF1 (6)
- MPI (6)
- YBX1 (6)
- AKT2 (5)
- ENG (5)
- GAPDH (5)
- ICAM3 (5)
- IRF6 (5)
- ITGAM (5)
- ITGB3 (5)
- MAPK8 (5)
- PDGFRA (5)
- SOX9 (5)
- SPN (5)
- ACTN1 (4)
- AKT3 (4)
- ANGPT1 (4)
- CD38 (4)
- CPA1 (4)
- EGF (4)
- GATA6 (4)
- HNF4A (4)
- ICAM1 (4)
- KLF5 (4)
- NEUROG3 (4)
- PDGFRB (4)
- PLAU (4)
- SRC (4)
- STAT5B (4)
- ACE (3)
- CDH5 (3)
- CSNK1A1 (3)
- CXCR4 (3)
- FOXA2 (3)
- GATA4 (3)
- GLI2 (3)
- HNF1B (3)
- IGFBP1 (3)
- IL6R (3)
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (334)
- Cell adhesion molecules (CAMs) (240)
- Focal adhesion (220)
- Colorectal cancer (186)
- T cell receptor signaling pathway (176)
- Hematopoietic cell lineage (155)
- MAPK signaling pathway (142)
- ErbB signaling pathway (138)
- Prostate cancer (137)
- Melanoma (131)
- Leukocyte transendothelial migration (130)
- Endometrial cancer (122)
- Neurotrophin signaling pathway (118)
- Cytokine-cytokine receptor interaction (117)
- Regulation of actin cytoskeleton (109)
- Toll-like receptor signaling pathway (108)
- Fc gamma R-mediated phagocytosis (107)
- Wnt signaling pathway (103)
- Acute myeloid leukemia (97)
- Jak-STAT signaling pathway (97)
- Pancreatic cancer (96)
- Renal cell carcinoma (94)
- Glioma (91)
- Small cell lung cancer (86)
- B cell receptor signaling pathway (84)
- Apoptosis (82)
- Adherens junction (81)
- Fc epsilon RI signaling pathway (81)
- Progesterone-mediated oocyte maturation (77)
- Non-small cell lung cancer (76)
- Chronic myeloid leukemia (75)
- Primary immunodeficiency (74)
- Insulin signaling pathway (72)
- Basal cell carcinoma (71)
- Epithelial cell signaling in Helicobacter pylori infection (71)
- GnRH signaling pathway (71)
- Tight junction (71)
- Melanogenesis (70)
- Endocytosis (64)
- Chemokine signaling pathway (63)
- Pathogenic Escherichia coli infection (63)
- VEGF signaling pathway (62)
- mTOR signaling pathway (61)
- Natural killer cell mediated cytotoxicity (54)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (51)
- Thyroid cancer (51)
- Type II diabetes mellitus (51)
- Adipocytokine signaling pathway (46)
- Antigen processing and presentation (45)
- ECM-receptor interaction (44)
- TGF-beta signaling pathway (42)
- Gap junction (41)
- Bladder cancer (40)
- Hedgehog signaling pathway (38)
- Prion diseases (38)
- Maturity onset diabetes of the young (36)
- ABC transporters (34)
- Amyotrophic lateral sclerosis (ALS) (33)
- Metabolic pathways (33)
- Calcium signaling pathway (31)
- Hypertrophic cardiomyopathy (HCM) (31)
- Notch signaling pathway (31)
- Dilated cardiomyopathy (28)
- Dorso-ventral axis formation (27)
- Phosphatidylinositol signaling system (26)
- Inositol phosphate metabolism (23)
- Renin-angiotensin system (23)
- Systemic lupus erythematosus (21)
- Axon guidance (20)
- NOD-like receptor signaling pathway (19)
- Alzheimer's disease (17)
- Viral myocarditis (17)
- Complement and coagulation cascades (16)
- RIG-I-like receptor signaling pathway (16)
- p53 signaling pathway (14)
- Long-term depression (12)
- Cardiac muscle contraction (11)
- Huntington's disease (11)
- Oocyte meiosis (10)
- Glutathione metabolism (9)
- Parkinson's disease (7)
- Amino sugar and nucleotide sugar metabolism (6)
- Autoimmune thyroid disease (6)
- Fructose and mannose metabolism (6)
- Glycolysis / Gluconeogenesis (6)
- Long-term potentiation (6)
- Nicotinate and nicotinamide metabolism (6)
- Vascular smooth muscle contraction (6)
- Type I diabetes mellitus (5)
- Vibrio cholerae infection (5)
- Allograft rejection (4)
- Graft-versus-host disease (4)
- Neuroactive ligand-receptor interaction (4)
- Retinol metabolism (4)
- Ubiquitin mediated proteolysis (3)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Linoleic acid metabolism (2)
- Lysosome (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Purine metabolism (2)
- Pyrimidine metabolism (2)
- Tyrosine metabolism (2)
- Cell cycle (1)
- Citrate cycle (TCA cycle) (1)
- Cysteine and methionine metabolism (1)
- PPAR signaling pathway (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Pyruvate metabolism (1)
- Regulation of autophagy (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)